Rethinking Innovation at FDA

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Disrupt the Disruptor: Rethinking 'Disruption' in Digital Innovation

Disruptive innovation has been described in the literature as a force that sweeps aside existing technology and business models. This paper presents a case study that aims to understand the disruptive nature of digital innovation. It questions how and why digital innovation comes to have (or not) a disruptive effect. It describes a case study of App and mobile innovation and offer preliminary f...

متن کامل

Rethinking the Energy-Efficiency Gap: Producers, Intermediaries, and Innovation

The economic justification for energy efficiency policy primarily focuses on market failures and barriers that prevent energy consumers from undertaking privately profitable investments in efficiency. These consumeroriented market imperfections are the subject of a substantial and growing body of research regarding human behaviour and economic incentives that influence the demand for energy-eff...

متن کامل

Cooperative Innovation in the Commons: Rethinking Distributed Collaboration and Intellectual Property for Sustainable Design Innovation

Addressing global design challenges in the environment and underserved communities requires a cooperative approach towards sustainable design innovation, one that embraces multidisciplinary expertise, participatory design and rapid dissemination of critical innovations in the field. How can a rural farmer in Botswana cooperatively develop appropriate solutions for his community with external re...

متن کامل

Participatory Loans and Innovation in Smes: Rethinking the Public Funding of Innovation Capabilities

There is a long research tradition around the existence of underinvestment problems that might arise in R&D and, more generally, innovative activities. These problems might become significant barriers to innovation in SMEs, due to the relationship between access to finance and production scale. However, previous literature is consistent with the hypothesis that innovative capabilities are not n...

متن کامل

Regulating off-label drug use--rethinking the role of the FDA.

The Food and Drug Administration (FDA) provides a barrier to market entry and use of unproven and unsafe products. For prescription drugs, the FDA approval process requires substantial evidence of efficacy and safety for specific clinical situations. Although approval is indication-specific, the FDA has a limited role once a drug is on the market. Recent draft guidelines covering manufacturers'...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Social Science Research Network

سال: 2023

ISSN: ['1556-5068']

DOI: https://doi.org/10.2139/ssrn.4373500